Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
Report: Most federally funded clinical trials for dementia have racially excluding criteria
By
Kristen Fischer
Jul 10, 2024
A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that weren’t...
Financial hardship drives unhappiness in people living with dementia, study finds
By
Kristen Fischer
Jan 05, 2024
A new study in the Journal of the American Geriatrics Society reveals just how tough it can be financially to live with dementia.
Remote staff training boosts quality of life, lowers sedative use in residents with dementia
By
Kristen Fischer
Jan 03, 2024
A digital training program improved the quality of life for nursing home residents with dementia, and reduced dependency on psychotropic meds.
Assisted living mental health services fell between 2019 and 2020, study finds
By
Kristen Fischer
Apr 25, 2024
Mental health visits for assisted living residents living with dementia dropped as the pandemic set in, a new study finds.
Study maps ‘home time’ for Medicare beneficiaries in assisted living communities
By
Kristen Fischer
Dec 21, 2023
A new study gives more insight into how much time older people in assisted living spend in and out of the setting.
At-home, finger-prick blood test for Alzheimer’s is latest touted stab at early diagnoses
By
Kristen Fischer
Aaron Dorman
Jul 25, 2023
A research team announced they were close to being able to diagnose Alzheimer’s disease using a finger prick blood test.